Cargando…
The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer
Tumorigenesis refers to the process of clonal dysplasia that occurs due to the collapse of normal growth regulation in cells caused by the action of various carcinogenic factors. These “successful” tumor cells pass on the genetic templates to their generations in evolutionary terms, but they also co...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566994/ https://www.ncbi.nlm.nih.gov/pubmed/34745998 http://dx.doi.org/10.3389/fonc.2021.759894 |
_version_ | 1784594138594803712 |
---|---|
author | Li, Jing Yu, Nan Li, Xin Cui, Mengna Guo, Qie |
author_facet | Li, Jing Yu, Nan Li, Xin Cui, Mengna Guo, Qie |
author_sort | Li, Jing |
collection | PubMed |
description | Tumorigenesis refers to the process of clonal dysplasia that occurs due to the collapse of normal growth regulation in cells caused by the action of various carcinogenic factors. These “successful” tumor cells pass on the genetic templates to their generations in evolutionary terms, but they also constantly adapt to ever-changing host environments. A unique peculiarity known as intratumor heterogeneity (ITH) is extensively involved in tumor development, metastasis, chemoresistance, and immune escape. An understanding of ITH is urgently required to identify the diversity and complexity of the tumor microenvironment (TME), but achieving this understanding has been a challenge. Single-cell sequencing (SCS) is a powerful tool that can gauge the distribution of genomic sequences in a single cell and the genetic variability among tumor cells, which can improve the understanding of ITH. SCS provides fundamental ideas about existing diversity in specific TMEs, thus improving cancer diagnosis and prognosis prediction, as well as improving the monitoring of therapeutic response. Herein, we will discuss advances in SCS and review SCS application in tumors based on current evidence. |
format | Online Article Text |
id | pubmed-8566994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85669942021-11-05 The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer Li, Jing Yu, Nan Li, Xin Cui, Mengna Guo, Qie Front Oncol Oncology Tumorigenesis refers to the process of clonal dysplasia that occurs due to the collapse of normal growth regulation in cells caused by the action of various carcinogenic factors. These “successful” tumor cells pass on the genetic templates to their generations in evolutionary terms, but they also constantly adapt to ever-changing host environments. A unique peculiarity known as intratumor heterogeneity (ITH) is extensively involved in tumor development, metastasis, chemoresistance, and immune escape. An understanding of ITH is urgently required to identify the diversity and complexity of the tumor microenvironment (TME), but achieving this understanding has been a challenge. Single-cell sequencing (SCS) is a powerful tool that can gauge the distribution of genomic sequences in a single cell and the genetic variability among tumor cells, which can improve the understanding of ITH. SCS provides fundamental ideas about existing diversity in specific TMEs, thus improving cancer diagnosis and prognosis prediction, as well as improving the monitoring of therapeutic response. Herein, we will discuss advances in SCS and review SCS application in tumors based on current evidence. Frontiers Media S.A. 2021-10-21 /pmc/articles/PMC8566994/ /pubmed/34745998 http://dx.doi.org/10.3389/fonc.2021.759894 Text en Copyright © 2021 Li, Yu, Li, Cui and Guo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Li, Jing Yu, Nan Li, Xin Cui, Mengna Guo, Qie The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer |
title | The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer |
title_full | The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer |
title_fullStr | The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer |
title_full_unstemmed | The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer |
title_short | The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer |
title_sort | single-cell sequencing: a dazzling light shining on the dark corner of cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566994/ https://www.ncbi.nlm.nih.gov/pubmed/34745998 http://dx.doi.org/10.3389/fonc.2021.759894 |
work_keys_str_mv | AT lijing thesinglecellsequencingadazzlinglightshiningonthedarkcornerofcancer AT yunan thesinglecellsequencingadazzlinglightshiningonthedarkcornerofcancer AT lixin thesinglecellsequencingadazzlinglightshiningonthedarkcornerofcancer AT cuimengna thesinglecellsequencingadazzlinglightshiningonthedarkcornerofcancer AT guoqie thesinglecellsequencingadazzlinglightshiningonthedarkcornerofcancer AT lijing singlecellsequencingadazzlinglightshiningonthedarkcornerofcancer AT yunan singlecellsequencingadazzlinglightshiningonthedarkcornerofcancer AT lixin singlecellsequencingadazzlinglightshiningonthedarkcornerofcancer AT cuimengna singlecellsequencingadazzlinglightshiningonthedarkcornerofcancer AT guoqie singlecellsequencingadazzlinglightshiningonthedarkcornerofcancer |